Q4 2017 Holdings
Filed 2018-02-14 | 52 holdings | $54.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $18.3M | 290,000 | 33.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $13.6M | 550,000 | 25.1% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $12.0M | 300,000 | 22.2% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $5.5M | 300,000 | 10.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $3.8M | 572,738 | 7.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $126.1K | 1,251,485 | 0.2% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $119.3K | 1,997,700 | 0.2% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $81.8K | 3,768,757 | 0.2% |
| Nektar Therapeutics(NKTREUR)Call | COM | 640268108 | $44.8K | 750,000 | 0.1% |
| Omeros Corp(OMER)Call | COM | 682143102 | $34.0K | 1,750,000 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $33.9K | 450,000 | 0.1% |
| Myokardia Inc | COM | 62857M105 | $33.7K | 800,000 | 0.1% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $33.0K | 3,656,669 | 0.1% |
| Inflarx NV(IFRX) | COM | N44821101 | $30.1K | 1,438,207 | 0.1% |
| Juno Therapeutics Inc | COM | 48205A109 | $25.1K | 550,000 | 0.0% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $25.1K | 900,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $22.5K | 1,231,522 | 0.0% |
| Quotient LTD | SHS | G73268107 | $22.2K | 4,488,121 | 0.0% |
| Avexis Inc | COM | 05366U100 | $22.1K | 200,000 | 0.0% |
| Proteostasis Therapeutics in | COM | 74373B109 | $19.2K | 3,300,000 | 0.0% |
| Quanterix Corp(QTRX) | COM | 74766Q101 | $18.2K | 847,789 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $17.8K | 897,505 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $17.0K | 875,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $15.5K | 200,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $14.2K | 80,000 | 0.0% |
| Anaptysbio Inc(ANAB)Call | COM | 032724106 | $13.6K | 135,000 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $13.6K | 1,940,880 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $10.6K | 337,876 | 0.0% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $9.1K | 575,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $9.0K | 700,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $8.3K | 400,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $8.0K | 297,803 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $7.1K | 202,079 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $7.1K | 333,166 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $6.6K | 400,000 | 0.0% |
| Gemphire Therapeutics Inc | COM | 36870A108 | $6.4K | 800,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $5.7K | 200,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $4.9K | 295,548 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $4.7K | 367,223 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $4.4K | 600,000 | 0.0% |
| Intec Pharma LTD Jerusalem | SHS | M53644106 | $4.2K | 809,804 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $4.1K | 500,000 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $3.7K | 607,903 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $3.6K | 200,000 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $3.6K | 3,550,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $3.2K | 75,000 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $2.9K | 296,296 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $2.2K | 223,972 | 0.0% |
| Oncobiologics Inc | COM | 68235M105 | $40 | 30,536 | 0.0% |
| Oncobiologics Inc | *W EXP 02/18/201 | 68235M113 | $13 | 416,666 | 0.0% |